Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of Cardinal Health, Inc. NYSE: CAH. In a filing disclosed on May 19th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cardinal Health stock on May 14th.
Representative Marjorie Taylor Greene also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 5/16/2025.
- Purchased $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Impinj NASDAQ: PI on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Corning NYSE: GLW on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Chevron NYSE: CVX on 5/14/2025.
- Purchased $15,001 - $50,000 in shares of UnitedHealth Group NYSE: UNH on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Blackstone NYSE: BX on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Hershey NYSE: HSY on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 5/14/2025.
Cardinal Health Stock Up 0.6%
Shares of NYSE:CAH opened at $154.71 on Wednesday. The business's 50 day moving average is $138.20 and its 200 day moving average is $128.37. The stock has a market cap of $36.93 billion, a P/E ratio of 28.86, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $156.44.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. During the same quarter last year, the firm posted $2.08 earnings per share. The business's revenue for the quarter was up .0% on a year-over-year basis. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be paid a dividend of $0.5107 per share. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.32%. The ex-dividend date is Tuesday, July 1st. Cardinal Health's payout ratio is currently 31.83%.
Analyst Ratings Changes
Several research firms have recently issued reports on CAH. Robert W. Baird upped their price objective on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. UBS Group upped their target price on Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a research report on Tuesday, April 29th. Morgan Stanley lifted their price objective on shares of Cardinal Health from $142.00 to $166.00 and gave the company an "overweight" rating in a research note on Monday, May 5th. Finally, Mizuho increased their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research note on Monday, March 31st. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $146.43.
View Our Latest Report on Cardinal Health
Institutional Investors Weigh In On Cardinal Health
Several institutional investors and hedge funds have recently added to or reduced their stakes in CAH. Belpointe Asset Management LLC lifted its stake in shares of Cardinal Health by 40.4% in the first quarter. Belpointe Asset Management LLC now owns 3,901 shares of the company's stock worth $538,000 after buying an additional 1,122 shares in the last quarter. Intech Investment Management LLC increased its stake in shares of Cardinal Health by 0.8% in the 1st quarter. Intech Investment Management LLC now owns 80,318 shares of the company's stock worth $11,065,000 after acquiring an additional 610 shares during the last quarter. SageView Advisory Group LLC raised its holdings in shares of Cardinal Health by 38.4% during the 1st quarter. SageView Advisory Group LLC now owns 5,228 shares of the company's stock worth $720,000 after acquiring an additional 1,450 shares during the period. Woodline Partners LP grew its holdings in shares of Cardinal Health by 3.6% in the first quarter. Woodline Partners LP now owns 763,472 shares of the company's stock valued at $105,184,000 after purchasing an additional 26,648 shares during the period. Finally, Zurich Insurance Group Ltd FI grew its holdings in shares of Cardinal Health by 4,935.9% in the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company's stock valued at $130,434,000 after purchasing an additional 927,950 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.
About Representative Greene
Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia's 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.
Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia's 14th Congressional District. She declared candidacy for the 2026 election.
About Cardinal Health
(
Get Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.